Mylan Laboratories Limited Lansoprazole Export Data — India (DGFT 2022–2026)

Name: Mylan Laboratories Limited Lansoprazole Export Records India — #2 Exporter, 416 Shipments, $20.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Lansoprazole

India Pharmaceutical Trade Intelligence

$290.2M316 Suppliers105 CountriesHS 30049034

ExportsIndia → CANADA54.9%India → UNITED STATES20.7%

ImportsISRAEL → India$8.3M UNITED STATES → India$178.0K

#1 Supplier: SANDOZ PRIVATE #1 Buyer: SANDOZ CANADA

Mylan Laboratories Limited — Lansoprazole Exporter #2 | $20.8M Trade Value | TransData Nexus | TransData Nexus

Mylan Laboratories Limited — Lansoprazole Exporter Profile

Indian Pharmaceutical Exporter · #2 for Lansoprazole · $20.8M export value · DGFT Verified

Mylan Laboratories Limited is the #2 Indian exporter of Lansoprazole with $20.8M in export value and 416 verified shipments. Mylan Laboratories Limited holds a 7.2% market share in Lansoprazole exports across 9 countries. The company exports 91 pharmaceutical products worth $634.8M across 26 therapeutic categories.

Mylan Laboratories Limited — Lansoprazole Export Profile: Buyers & Destinations

Mylan Laboratories Limited Lansoprazole export treemap — buyers and destination countries | TransData Nexus

Where Does Mylan Laboratories Limited Export Lansoprazole?

Country	Value	Shipments	Share
FRANCE	$4.7M	147	39.9%
NETHERLANDS	$3.2M	134	27.0%
UNITED STATES	$2.7M	72	22.7%
CANADA	$598.9K	22

Who Are the Top Buyers of Lansoprazole from Mylan Laboratories Limited?

Buyer	Country	Value	Orders
MYLAN IRELAND C/O ALLOGA RDC,	NETHERLANDS	$1.7M	81
MYLAN PHARMACEUTICALS INC,	UNITED STATES	$1.2M	34
MYLAN PHARMACEUTICALS INC	UNITED STATES	$874.0K	22
CSP VIATRIS SANTE AT CSP-LAB	FRANCE	$826.1K	28
MYLAN IRELAND C/O ALLOGA RDC	NETHERLANDS	$680.2K	27
CSP VIATRIS SANTE AT CSP- LAB	FRANCE	$659.4K	18
CSP VIATRIS SANTE AT CSP- LAB,	FRANCE	$616.9K	28
CSP MYLAN SAS AT CSP LABO 274	FRANCE	$608.9K	17
CSP VIATRIS SANTE AT CSP LAB	FRANCE	$598.0K	16
CSP VIATRIS SANTE AT CSP- LABO,	FRANCE	$569.1K	16

Mylan Laboratories Limited supplies Lansoprazole to 37 buyers globally. The largest buyer is MYLAN IRELAND C/O ALLOGA RDC, (NETHERLANDS), followed by MYLAN PHARMACEUTICALS INC, (UNITED STATES) and MYLAN PHARMACEUTICALS INC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Lansoprazole Formulations Does Mylan Laboratories Limited Export?

Product Description / Formulation	Value	Shipments
LANSOPRAZOLE DELAYED RELEASE CAPSULES US	$700.0K	21
HARMLESS MEDICINES, LANSOPRAZOLE MYLAN 3	$430.6K	13
HARMLESS MEDICINES, LANSOPRAZOLE 30MG OR	$332.7K	10
LANSOPRAZOLE DELAYED-RELEASE ORALLY DISI	$188.5K	5
LANSOPRAZOLE 15MG ORO-DISPERSIBLE TABLET	$172.4K	4
HARMLESS MEDICINES MYLAN-LANSOPRAZOLE 3	$150.0K	3
DEXLANSOPRAZOLE DELAYED RELEASE CAPSULES30 MG 30BT PACKS 108528NOS	$150.0K	3
DEXLANSOPRAZOLE DELAYED RELEASE CAPSULES60 MG 30BT PACKS 204168NOS	$150.0K	3
DEXLANSOPRAZOLE DELAYED RELEASE CAPSULES60 MG 90BT PACKS 16872NOS	$144.4K	3
LANSOPRAZOLE MYLAN 30 MG 28BL TAB PACKS	$143.8K	4

Mylan Laboratories Limited exports 253 distinct Lansoprazole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is LANSOPRAZOLE DELAYED RELEASE CAPSULES US with 21 shipments worth $700.0K.

How Does Mylan Laboratories Limited Compare to Nearest Lansoprazole Exporters?

Exporters ranked immediately above and below #2 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	MYLAN LABORATORIES LIMITED ★	$20.8M	416	9	$50.0K
5	CIPLA LIMITED	$11.3M	267	9	$42.4K
6	CAPLIN POINT LABORATORIES LIMITED	$6.4M	128	7	$50.0K

Mylan Laboratories Limited ranks #2 among 316 Indian Lansoprazole exporters. Average shipment value of $50.0K compared to the market average of $227.0K. The closest competitors by value are CIPLA LIMITED and CAPLIN POINT LABORATORIES LIMITED.

Which Indian Ports Ship Lansoprazole Exports?

Port	Shipments	% Share
SAHAR AIR	729	15.0%
DELHI AIR CARGO ACC (INDEL4)	577	11.9%
SAHAR AIR CARGO ACC (INBOM4)	416	8.5%
DELHI AIR	364	7.5%
NHAVA SHEVA SEA (INNSA1)	264	5.4%
JNPT/ NHAVA SHEVA SEA	209	4.3%
Bombay Air	140	2.9%
JNPT	106	2.2%

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Lansoprazole Exports

Mylan's export operations are influenced by a complex geopolitical landscape. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structure for Indian pharmaceutical exporters like Mylan. Additionally, diversions around the Cape of Good Hope have further elongated delivery schedules, posing challenges to time-sensitive pharmaceutical shipments.

In the United States, the imposition of tariffs on pharmaceutical imports has prompted Indian companies to reassess their market strategies. While generics have largely remained exempt, the potential for future tariff expansions necessitates vigilance. Mylan, along with other Indian exporters, is exploring market diversification to mitigate reliance on the U.S. market. The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a strategic avenue for expansion. The FTA eliminates tariffs on approximately 97% of EU tariff lines, including pharmaceuticals, thereby enhancing market access for Indian exporters. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, providing a counterbalance to uncertainties in the U.S. market.

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains paramount for Mylan. The FDA's warning letter and import alert in December 2024 concerning the Indore facility underscore the critical importance of stringent quality control measures. The cited violations, including subpar quality control and improper management of manufacturing defects, have necessitated comprehensive corrective actions. Mylan's proactive response aims to restore compliance and reinforce its commitment to quality assurance.

The evolving regulatory environment, particularly in the European Union, further emphasizes the need for adherence to Good Manufacturing Practices (GMP). The EU's Falsified Medicines Directive mandates rigorous compliance to ensure product integrity and patient safety. For Mylan, aligning with these standards is essential to maintain and expand its foothold in the European market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Lansoprazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Mylan Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 416 individual customs records matching Mylan Laboratories Limited exporting Lansoprazole, covering 253 formulations to 9 countries via 37 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 105+ countries, 687+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Lansoprazole

Lansoprazole

Mylan Laboratories Limited — Lansoprazole Exporter Profile

Mylan Laboratories Limited — Lansoprazole Export Profile: Buyers & Destinations

Where Does Mylan Laboratories Limited Export Lansoprazole?

Who Are the Top Buyers of Lansoprazole from Mylan Laboratories Limited?

What Is India's Total Lansoprazole Export Value and How Much Does Mylan Laboratories Limited Contribute?

What Is the Average Shipment Value for Mylan Laboratories Limited's Lansoprazole Exports?

How Does Mylan Laboratories Limited Compare to Other Indian Lansoprazole Exporters?

What Lansoprazole Formulations Does Mylan Laboratories Limited Export?

Regulatory Requirements: Exporting Lansoprazole to Key Markets

United States — FDA

How Does Mylan Laboratories Limited Compare to Nearest Lansoprazole Exporters?

Which Indian Ports Ship Lansoprazole Exports?

What Other Gastrointestinal Products Does Mylan Laboratories Limited Export?

Lansoprazole — Export Intelligence Video

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Lansoprazole Exports

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

About Mylan Laboratories Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Lansoprazole Export Data from Mylan Laboratories Limited

Lansoprazole Stats

Company Overview

Top Products by Mylan Laboratories Limited

Related Analysis

Need Detailed Export Data?

Data Source